- Research works
- 46 ▲ 40% vs 2013–17
- Citations
- 532 11.6 per fractional work
- Top-10% rate
- 9.2% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: Lee's Pharmaceutical (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 13.5×
- Chemistry 6.1×
- Biochemistry, Genetics and Molecular Biology 4.2×
- Immunology and Microbiology 4.1×
- Medicine 2.6×
- Mathematics 0.7×
- Neuroscience 0.4×
- Engineering 0.3×
- Materials Science 0.2×
- Computer Science 0.2×
- Health Professions 0.1×
- Earth and Planetary Sciences 0.1×
- Environmental Science 0.0×
Which keywords describe research at Lee's Pharmaceutical (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Therapy, Chemotherapy, Glycemic Control, Insulin Therapy, Angiogenesis, Tumor Microenvironment and PET Imaging.
- Chimeric Antigen Receptor
- Type 2 Diabetes
- Hemostasis
- Cancer Immunotherapy
- Clinical Guidelines
- Targeted Therapy
- N-terminal Acetylation
- Fibroblast Activation Protein
- Cardiovascular Disease
- Angiogenesis
- Glycemic Control
- Cancer Therapy
- Immunotherapy
- Chemotherapy
- Insulin Therapy
- Tumor Microenvironment
- PET Imaging
- Immunosuppression
- Heart Failure
- Cancer
- BET Bromodomains
- Diabetes
- PROTACs
- CAR T Cells
- Lymphoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 25 words, with their numbers
- Immunotherapy3▲ 21×8 topics
- Cancer Therapy3▲ 22×5 topics
- Chemotherapy2▲ 13×9 topics
- Glycemic Control2▲ 55×2 topics
- Insulin Therapy2▲ 70×2 topics
- Angiogenesis2▲ 25×2 topics
- Tumor Microenvironment2▲ 17×3 topics
- Cardiovascular Disease2▲ 6.3×5 topics
- PET Imaging2▲ 41×3 topics
- Fibroblast Activation Protein1▲ 153×1 topic
- Immunosuppression1▲ 75×2 topics
- N-terminal Acetylation1▲ 153×1 topic
- Heart Failure1▲ 15×2 topics
- Targeted Therapy1▲ 28×5 topics
- Cancer1▲ 4.3×7 topics
- Clinical Guidelines1▲ 20×2 topics
- BET Bromodomains1▲ 182×1 topic
- Cancer Immunotherapy1▲ 33×2 topics
- Diabetes1▲ 11×3 topics
- Hemostasis1▲ 53×2 topics
- PROTACs1▲ 182×1 topic
- Type 2 Diabetes1▲ 24×2 topics
- CAR T Cells1▲ 66×1 topic
- Chimeric Antigen Receptor1▲ 66×1 topic
- Lymphoma1▲ 31×2 topics
Which research topics does Lee's Pharmaceutical (China) publish most on?
By volume in 2022–2025: Peptidase Inhibition and Analysis, Protein Degradation and Inhibitors, CAR-T cell therapy research and Diabetes Treatment and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Peptidase Inhibition and Analysis Oncology 1 works
- 2 Protein Degradation and Inhibitors Molecular Biology 1 works
- 3 CAR-T cell therapy research Oncology 1 works
- 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 5 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
- 6 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 7 Venomous Animal Envenomation and Studies Genetics 1 works
- 8 Analytical Methods in Pharmaceuticals Analytical Chemistry 1 works
- 9 Spectroscopy and Chemometric Analyses Analytical Chemistry 1 works
- 10 Protein purification and stability Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Lee's Pharmaceutical (China)'s research output changed?
Output in 2018–2022 was 40% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.